Begrunnelse:
Enhver undersøkelse er en belastning for alvorlig syke pasienter. Indikasjonen må derfor være godt gjennomtenkt.
Referanser:
- Fisher DA, et al. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005 Nov;100(11):2526-30. PMID: 16279910.
- Lee SJ, et al. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013 Jan 8;346:e8441. PMID: 23299842.
- Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Jul 17;157(2):120-34. PMID: 22801674.
- Schroder FH, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012 Mar 15;366(11):981-90. PMID: 22417251.
- Nasjonale faglige retningslinjer (Helsedirektoratet.no)